Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | TNF | P01375 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.45 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27129094 | 0.98 | TSHR (0.51) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL27129012 | 0.98 | MAPT (0.54) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL25668527 | 0.98 | MAPT (0.54) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL25668538 | 0.98 | MAPT (0.54) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL27456041 | 0.98 | MAPT (0.54) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL27129093 | 0.97 | TSHR (0.50) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL23921203 | 0.96 | HDAC8 (0.50) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL23633622 | 0.96 | MAPT (0.56) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL24582816 | 0.96 | MAPT (0.56) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 | |
| SCHEMBL25668530 | 0.96 | MAPT (0.56) | MAPTSMN1; SMN2TSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074311-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | RPS12, TCF12, RRP12 | MAPT 3009/4885SMN1; SMN2 3003/4885TSHR 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.